Senolytics Therapy
Readiness
TRL 4 · SRL 6 · gap -2
Gap = technical readiness − societal readiness. Positive: the technology is ready and society is not. Negative: society wants it more than the technology can deliver.
Hype risk: expectations are running ahead of what the technology can deliver.
Not scored. Watchlist entries do not enter any gradient.
Drugs that selectively kill senescent cells — cells that have stopped dividing but persist, secreting inflammatory signals, accumulating with age.
The biology is one of the better-supported mechanisms in ageing research. Clearing senescent cells in mice extends healthy lifespan and improves function across several tissues, and that result has replicated. The candidate compounds are largely repurposed drugs, which shortens the path.
Technical readiness 4 against societal readiness 6, and that two-point gap is the entry's point. The appetite for a treatment that slows ageing is close to unlimited, human trials are early and have produced mixed results, and the space between those two facts is already full of supplements sold on the strength of the mouse data. Chapter 14's mechanism is operating here in a consumer market rather than a policy one.
Common misconception: that the mouse results transfer. Interventions that extend mouse lifespan have a long history of not extending human lifespan, and this one is at the beginning of finding out.
What it does
mechanism — not yet written. Published as missing rather than hidden.